Hosted on MSN8d
Report: Generic prescriptions marked up 5,000%A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
the FTC said in its second report on the industry. "The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an ...
Experts explain why the U.S. Court of Appeals for the Fifth Circuit struck down a rule that they say could have help consumers save billions in the car buying process.
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
Denton comes to the FTC as the agency's new chairman, Andrew Ferguson, begins to build his agenda. Ferguson previously ...
The Federal Trade Commission (FTC) released a 60-page report Tuesday targeting the three biggest pharmacy benefit managers (PBMs), claiming the companies hiked the prices of specialty drugs by ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
The Federal Trade Commission filed 2 Robinson-Patman suits at the end of the Biden Administration. RPA suits penalize ...
On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark ...
The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S., in the latest and likely ...
The Federal Trade Commission (FTC) says that if you received an unsolicited text message claiming you owe money for unpaid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback